| 90 |
X |
X |
X |
2021 |
Int. J. Mol. Sci. 22(16), 8605 (2021) |
The Use of Total Thrombus Formation Analysis System as a Tool to Assess Platelet Function in Bleeding and Thrombosis Risk—A Systematic Review
|
J Sikora
|
| 85 |
|
X |
|
2021 |
J Clin Med 10(5):1024 (2021) |
Prostacyclin Analogues Inhibit Platelet Reactivity, Extracellular Vesicle Release and Thrombus Formation in Patients with Pulmonary Arterial Hypertension
|
A Gąsecka
|
| 89 |
|
X |
|
2021 |
Sci Rep 11(1):11472(2021) |
Development of anti-thrombotic vaccine against human S100A9 in rhesus monkey
|
M Shimamura
|
| 88 |
X |
X |
|
2021 |
Acute Med Surg 8(1):e648(2021) |
Influence of high‐dose antithrombin on platelet function and blood coagulation
|
T Miike
|
| 87 |
|
X |
|
2021 |
J Functional Foods 80, 104438(2021) |
Anti-platelet activity of phytocompounds in various dandelion organs in human whole blood model in vitro
|
B Lis
|
| 86 |
|
X |
|
2021 |
Int J Mol Sci 22(6):3282(2021) |
Anti-Platelet Properties of Phenolic and Nonpolar Fractions Isolated from Various Organs of Elaeagnus rhamnoides (L.) A. Nelson in Whole Blood
|
B Skalski
|
| 83 |
|
X |
|
2021 |
Biomed Pharmacother 137, 111395(2021) |
Multidirectional effects of saponin fraction isolated from the leaves of sea buckthorn Elaeagnus rhamnoides (L.) A. Nelson
|
M Juszczak
|
| 79 |
|
X |
|
2021 |
Platelets 1-5(2021) |
The Total Thrombus Formation (T-TAS) platelet (PL) assay, a novel test that evaluates whole blood platelet thrombus formation under physiological conditions
|
KL Zheng
|
| 78 |
|
X |
|
2021 |
Thromb Haemost |
Assessment of Platelet Thrombus Formation under Flow Conditions in Adult Patients with COVID-19: An Observational Study
|
S Ghirardello
|
| 72 |
X |
X |
|
2020 |
Pol Arch Intern Med 130(12),p1114-1117(2020) |
Can Total Thrombus-formation Analysis System (T-TAS®) better predict coagulation disturbances than conventional laboratory measurements in patients with polycystic ovary syndrome?
|
K Ożegowska
|
| 71 |
|
X |
|
2020 |
J Clin Med 9(8):2636(2020) |
Advances in Platelet Function Testing-Light Transmission Aggregometry and Beyond
|
JL Blanc
|
| 69 |
X |
X |
|
2020 |
Pediatr Int (2020) |
A microchip flow-chamber assay screens congenital primary hemostasis disorders
|
Y Nakajima
|
| 67 |
X |
X |
|
2020 |
Kardiol Pol 78(7-8),p667-673(2020) |
New methodological approaches for assessing thrombus formation in cardiovascular disease
|
K Hosokawa
|
| 66 |
|
X |
|
2020 |
J Pediatr S0022-3476(20),p30726-30735(2020) |
Assessment of Platelet Thrombus Formation under Flow Conditions in Patients with Acute Kawasaki Disease
|
N Tsujii
|
| 65 |
|
X |
|
2020 |
Br J Haematol 191(1), e7-e10(2020) |
Evaluation of the Potential Utility of the Total Thrombus-Formation Analysis System in Comparison to the Platelet Function Analyser in Subjects With Primary Haemostatic Defects
|
J Charpy
|
| 62 |
X |
X |
|
2020 |
Front Vet Sci 7:307(2020) |
A Novel Microchip Flow Chamber (Total Thrombus Analysis System) to Assess Canine Hemostasis
|
T Iwanaga
|
| 60 |
X |
X |
|
2020 |
Circ J 84(6),p975-984(2020) |
Platelet-Derived Thrombogenicity Measured by Total Thrombus-Formation Analysis System in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
|
S Kikuchi
|
| 59 |
|
X |
|
2019 |
Haematologica 235549(2019) |
Novel aptamer to von Willebrand factor A1 domain (TAGX-0004) shows total inhibition of thrombus formation superior to ARC1779 and comparable to caplacizumab
|
K Sakai
|
| 58 |
X |
X |
|
2019 |
Int J Hematol 111, p369-377(2020) |
Evaluation of clinical severity in patients with type 2N von Willebrand disease using microchip-based flow-chamber system
|
Y Nakajima
|
| 57 |
X |
X |
|
2019 |
J Atheroscler Thromb 27(3),p201-203(2020) |
Monitoring of Antithrombotic Therapy
|
M Yamazaki
|
